Good morning everyone, and welcome. My name is Sakari Järvelä, and I am happy to present the financial results for the second quarter and the first half of 2026. As Anssi already said, we're extremely pleased to report excellent second quarter results with comparable operating profit of €43.7 million, one of the highest quarterly profits in history. Starting from the net interest income, as we had indicated in previous quarters, that declining trend turned in the second quarter as the reported NII grew 3% compared to the first quarter. Overall, we reported €33.1 million in net interest income in the second quarter and €65.1 million in the first half, which is still below last year. But the quarterly trend is now increasing. Both the loan book and deposit stock decreased slightly during the quarter. NCI growth at 7% compared to the same period last year is one of the highlights of the quarter, something we are very proud of, as it signals that we are delivering on one of the core parts of our strategy in the life insurance business. We reported exceptionally high net income of €14.1 million in the quarter, as the effects from the shifting interest rate curve and overall market turmoil corrected from a very weak first quarter. Looking at the first half. In total, we reported net income from life insurance of €15.1 million, which is 4% ahead of last year. The one large individual impact that contributed to the close to record comparable operating profit comes from the implementation of the new expected credit loss model. This generated €8.1 million profit impact during the quarter, in line with what we had already announced in April. Another one-off item worth paying attention to is the approximately 1 million euro gain we booked from reorganizing our liquidity portfolio, shown in the other income line on the capital side. Our CET1 capital ratio was 12%, down 0.8% from the previous quarter. This decrease was due to the new IRB models being taken into use, again, in line with what we had already announced before. From a segment perspective, all our three business units grew top-line in the quarter compared to last year, with solid quarters from both banking and asset management segments. So we are truly firing from all cylinders in our business. Then, turning to life insurance. We spent a lot of time and effort in our Q1 call explaining why the weak result in life insurance was not something we were particularly concerned about. Now we are happy to be able to confirm this in actual numbers, as the net income from life insurance in Q2 was at an exceptional level. The largest part of this excellent result derives from the recovery in the with-profit portfolio. The with-profit portfolio recovered from the very weak Q1, driven by a correction in the valuations of both the investment portfolio assets and the discounted value of the liabilities. We can never rule out other similar periods of volatility during the rest of the year, but barring that, we could say that after the H1 result, our with-profit portfolio is now back at a normalized level. The risk life insurance business also had a solid quarter following a slightly weaker Q1. This is one of our core strategic focus areas, so we are obviously very happy to see that. The unit-linked business also had another good quarter, with AuM again reaching a new record level. So Q2 delivered a very strong recovery for our life insurance business. Not only that, but we also delivered a very strong underlying performance. The development of net commission income in the quarter was really, as I said, one of the highlights. In total, NCI grew by 7% year-on-year, and within this, the mutual funds and asset management were the drivers, growing by over 9%. The strength of this result is further underlined by the fact that we have an ongoing restructuring project in our cards offering, which generated some transition costs weighing on the result. Our lending fees grew year-on-year, but also from the last quarter. Although activity in the loan market in general is still not at a very high level. NCI growing by over 5% is one of our key financial targets, and we are very happy to be on that trajectory. As mentioned earlier, in Q2, we did witness the turn in the net interest income as the quarterly NII grew from the previous quarter, having declined for nine quarters in a row following the higher interest rates. Our loan book was stable in the quarter, and deposit stock declined very slightly. This downward movement in deposits was, however, a result of certain larger corporate deposits converting into AuM, while household deposits increased slightly. We expect the net interest income dynamic going forward to remain positive, as the interest rate increase we have seen in 2026 will work its way through the interest income. As we have stated before, we do undertake standard hedging measures for the deposit side, which means that any market rate moves will come through with a lag. So the full effect of the higher rates will only be felt fully next year. On the cost side, we had a rather uneventful quarter with a planned moderate 3% increase in operating costs compared to last year. Our personnel costs are very well in check, considering the collective agreements for salary increases in the sector and also relative to our peers; IT costs are increasing as we continue to invest in data and AI capabilities, and previous years' higher CapEx shows in a slightly increasing depreciation charge. As explained in detail in our Q1 presentation, during the quarter we had two important model implementations. First, we implemented our new IRB models in June, which affected both our risk-weighted assets and also our capital. The final impact from the new models to our CET1 capital ratio was slightly over 1%, in line with what we had guided in Q1. And secondly, we also implemented our new ECL model in June, which decreased the expected credit loss provisions by 8.1 million, again in line with the 7.7 to 10 million guidance we gave in Q1. This impact was recognized on our P&L as already discussed. Looking at the credit loss provisions in more detail, we can see the impact of the new ECL model in declining impairment for the loan book in all three stages of the impairment cycle. Disregarding the impact from the new model, it is important to note that our ECL provisions continue to be at a low level, highlighting the health of our balance sheet. Finally, noting that the relatively large number in the quarter for realized losses, which have already been written off and removed from the impairments, primarily consists of a large case which was provisioned during 2025.
CET1 ratio at the end of the quarter was 12%, down from 12.8% in the previous quarter, but well within the upper part of our target range of 2 to 4% above the regulatory minimum. As previously discussed, the new IRB models affected the ratio negatively by slightly over 1%. While minor restructuring of the holdings in our liquidity portfolio had a positive effect, according to our capital policy, we would like our capitalization to be at a level that is prudent but efficient. So even after the slight drop in the CET1 ratio, we are pleased where we are with our capitalization level right now. On the funding side, we have no large needs in the near future after the successful refinancings earlier in the year, but we continue to monitor the senior preferred private placement market for any refinancing needs. Aktia Life Insurance has a tier two instrument, for which it has applied for a permit to call with a plan to replace and refinance the note in due course. So we are following that market as well.
Then moving on to the outlook for the rest of the year. Our guidance is that the comparable operating profit is expected to be approximately at the same level, or slightly higher than the 106 million euro in 2025. We reported 62.4 million in operating profit for the first half, which included relatively large positive one-off items. The new ECL model in particular. Our current expectation is that the underlying performance in the second half of the year should be roughly similar to the first. In giving our guidance, we recognize the volatile nature of our life insurance business, which at times may have a meaningful impact on our results if market conditions change, as we saw during the Q1 this year. Hence, at this point of the year, we are still reaffirming our guidance, but are adding a further note that the result could be slightly higher than last year. Again, we will review our guidance throughout the year as more data becomes available. This completes our review for the second quarter results.
So thank you for listening. And we are now happy to take your questions. We are now ready to answer your questions. The Q&A session will be moderated by Oscar. Thank you.